All results

1 results for impact

• VX21-522-001

  The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and…

  Ages

  18 Years - 65 Years

  Sexes

  All